ISPOR - Examining the budget impact of adopting netupitant/palonosetron for the prevention of chemotherapy induced nausea and vomiting in a u.s. Health plan

Full Text

Examining the budget impact of adopting netupitant/palonosetron for the prevention of chemotherapy induced nausea and vomiting in a u.s. Health plan

Abstract

Authors

R.L. Knoth S. Abouzaid C. Faria A. Powers

Back to Volume 18, Issue 3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now